Treatment & Prognosis of Promyelocytic Leukemia

Treatment & Prognosis of Promyelocytic Leukemia thumbnail
Treatment & Prognosis of Promyelocytic Leukemia

Promyelocytic leukemia--also known as APL, or acute progranulocytic leukemia--is a specific form of leukemia, or cancer of the blood. While many types of leukemia are difficult to treat and control, there are a number of highly successful promyelocytic leukemia treatments that can greatly increase the chance of recovery from the disease.

  1. Definition

    • In individuals suffering from promyelocytic leukemia, the bone marrow produces such an excess of abnormal white blood cells that the regular production of red blood cells is disrupted. As the disease progresses, symptoms include unexplained weight loss, anemia, a tendency to bruise and/or bleed easily, shortness of breath, weakness and an abnormal susceptibility to infections.

    Treatments

    • There are three main types of treatments used for patients with promyelocytic leukemia: treatment with ATRA (all-trans retinoic acid), stem cell transplantation, and treatment with an oxide of arsenic, known as arsenic trioxide. However, the most successful treatment option of all three is the use of ATRA.

    ATRA Treatment

    • ATRA treatment in promyelocytic leukemia patients induces the abnormal white blood cells in the bone marrow to develop into mature white blood cells; this differentiation causes them to stop proliferating and crowding out the production of red blood cells. ATRA treatment is commonly used in conjunction with chemotherapy, since the two together have proven to be more effective than ATRA treatment alone.

    Side Effects of ATRA

    • ATRA treatment has one major side effect: the development of retinoic acid syndrome, a serious condition that causes weight gain, severe shortness of breath, a sharp drop in blood pressure, and fever. If a promyelocytic leukemia patient develops retinoic acid sydrome, she must be treated with dexamethasone, a strong immunosuppressant.

    Prognosis

    • With the use of ATRA treatment, over 90 percent of promyelocytic leukemia patients end up going into remission. If the ATRA treatment is combined with chemotherapy, nearly 75 percent can be completely cured.

Related Searches:

References

Resources

  • Photo Credit Microsoft Office Online

You May Also Like

  • Acute Promyelocytic Leukemia Symptoms

    Acute promyelocytic cancer is a subset of leukemia, appearing most often in children. Unlike some cancers, which originate in a specific body...

  • What Is Acute Promyelocytic Leukemia?

    Acute promyelocytic leukemia is a type of cancer, in the leukemia category of cancer disease processes. This condition is considered a sub-classification...

  • Acute Monocytic Leukemia Treatment

    Acute monocytic leukemia (AML) is a form of cancer that affects the bone marrow and blood. Blood cells and platelets are produced...

  • What Are the Treatments for M3 Leukemia?

    According to the Leukemia and Lymphoma Society, more than 13,000 people in the United States were diagnosed with acute myeloid leukemia (AML)...

  • Types of Leukemia in Adults

    Leukemia is a blood cancer originating in the myeloid or lymphoid stem cells, which produce leukocytes (white blood cells) and other cells...

  • What Are the Treatments for AML Subtypes?

    What Are the Treatments for AML Subtypes?. More than 12,000 Americans are diagnosed annually with acute myeloid leukemia (AML, also known as...

  • Leukemia Treatment Protocol

    Per the Mayo Clinic, leukemia is a form of cancer that affects the tissues responsible for forming blood. Most cases originate in...

  • Is Leukemia Hereditary?

    Though most people are relatively familiar with leukemia, there are still many people that have never been touched by the disease. And...

  • Oncology and Leukemia

    Oncology is the field of medicine devoted to the study and treatment of cancer. Within this field are three primary specialties: medical,...

Related Ads

Featured